What We're Reading: Page 316
Industry reads hand-picked by our editors
May 22, 2017
-
The Wall Street Journal
Dutchman who had trouble finding job at home became CEO of a U.S. biotech pioneer
-
MIT Technology Review
Microsoft has a goal to store data as DNA
-
The New York Times
A vital drug runs low, though its base ingredient is in many kitchens
May 19, 2017
May 18, 2017
-
The Wall Street Journal
As states wage battles on high drug prices, drugmakers fight back
-
Bloomberg
Pharma heir seeks a new Holy Grail as generic drugs run dry
-
Quartz
Syphilis is on the rise because penicillin isn’t profitable
-
The Washington Post
What Amazon could do to the business of selling prescription drugs
May 17, 2017
May 16, 2017
-
Bloomberg
Samsung looks beyond smartphones to next-gen biologics
-
Fortune
Why the companies that actually make your drugs are in a merger frenzy
-
The Seattle Times
Genoa Pharmaceuticals, led by biotech veteran Bruce Montgomery, raises $62M to fund clinical trials
-
The New York Times
When the immune system thwarts lifesaving drugs
May 15, 2017
-
Crain's Detroit Business
Life after Pfizer: A decade later, Michigan pharmaceutical companies have found paths to growth
-
The Boston Globe
Henri Termeer, key biotech leader who built Genzyme into an industry giant, dead at 71
-
Forbes
Pharma's not so stingy with R&D after all
-
Phys.org
Cutting-edge analysis reveals how different drugs interact with the same target
Previous
